Europe Artificial Organ and Bionics Market Outlook, 2029

The Europe Artificial Organ and Bionics Market is estimated to reach €22.4 billion by 2027, driven by stringent regulatory framework.

According to publisher, Europe's artificial organs and bionics market is a powerhouse of innovation, renowned for its focus on high-quality medical devices and a commitment to patient safety. This report dives into the market's value, growth drivers, dynamics, segmentation, regional variations, key advancements, and the competitive landscape. Market Insights:

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Value and Growth: The European artificial organs and bionics market is estimated to reach €22.4 billion by 2027 showcasing steady growth. While not the largest market, Europe is a key player due to: Strong Research Infrastructure: Europe is home to leading research institutions and universities fostering advancements in biomaterials and artificial organ development. Example: Collaborations between research centers like Max Planck Society in Germany and medical device companies accelerate the development of new technologies. Stringent Regulatory Framework:

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Europe enforces rigorous regulations (e.g., EMA guidelines) ensuring the safety and efficacy of artificial organs and bionics. This builds trust in European-made devices globally. Example: The thorough approval process for these technologies in Europe guarantees a high standard for patient safety. Aging Population: Similar to other regions, Europe faces an aging population, driving demand for artificial organs and bionics to treat age-related conditions like heart failure and vision loss. Example: Increased production of artificial pacemakers and bionic eye implants to address the needs of the elderly population across Europe. Market Dynamics The European market is a complex ecosystem shaped by several key trends:

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Shift Towards Specialty Devices: * The market is witnessing a rise in specialty devices like bionic limbs with advanced functionalities and artificial hearts designed for specific patient needs. * Example: Companies might develop bionic arms with improved dexterity and mind-control capabilities for amputees. Focus on Cost-Effectiveness: * Rising healthcare costs are pressuring manufacturers to control device prices. This leads to a rise in exploring cost-effective production methods. * Example: European governments might incentivize companies to develop more affordable versions of artificial organs and bionics to improve patient access. Sustainability Considerations: * Environmental concerns are driving efforts towards sustainable manufacturing practices within the industry. Companies are exploring ways to reduce waste and minimize the environmental impact of production processes. * Example: A manufacturer might invest in energy-efficient production facilities or develop recycling programs for specific materials used in artificial organs and bionics. Market Segments The European market can be segmented based on various criteria: Product Type: The market offers a wide range of products, including artificial hearts, cochlear implants, advanced prosthetics, and biocompatible materials. Therapeutic Area: * Devices are developed to target specific therapeutic areas like cardiology, neurology, ophthalmology, and orthopedics. Regional Analysis While Europe functions as a single market, there are variations in terms of specialization and production strength within the region: Western Europe: * Western Europe, particularly Germany, France, and Switzerland, is a hub for research and development, housing major medical device companies and renowned research centers. * Example: Many leading players in artificial organs and bionics have their headquarters or major R&D facilities in Western Europe. Eastern Europe: * Eastern Europe, like Poland and Hungary, is emerging as a cost-competitive manufacturing hub, attracting companies seeking lower production costs. * Example: A Western European company might establish a manufacturing plant in Eastern Europe to produce specific artificial organ components at a lower cost while maintaining European quality standards. Key Developments The European market is constantly evolving: Digitalization and Automation: * The industry is embracing digitalization and automation to streamline production processes, improve quality control, and leverage data analysis for better device design. * Example: Companies might utilize AI-powered systems to optimize manufacturing processes and predict potential quality issues in artificial organs before implantation. Open Collaboration: * Collaboration between medical device companies, universities, and research institutions is fostering open innovation, accelerating the development of new and improved artificial organs and bionics. * Example: A university bioengineering department might partner with a medical device company to develop a novel type of biocompatible material for artificial organs. Competitive Landscape The European market boasts a competitive landscape with established players and emerging companies: Specialty Medical Device Companies: * Alongside Big Pharma, smaller European companies specializing in niche areas like cochlear implants or artificial heart valves are gaining traction. * Example: A French company might focus on developing innovative cochlear implants with improved sound quality and functionality for individuals with hearing loss. Emerging Startups: * Innovative startups are emerging across Europe, focusing on disruptive technologies and personalized medicine approaches. * Example: A German startup might develop a 3D-printing technology that allows for the creation of customized prosthetic limbs with improved anatomical fit and user comfort. Research Institutions and Universities: * European research institutions play a crucial role in driving innovation. They contribute to groundbreaking research and often collaborate with private companies for commercialization. * Example: A university in Switzerland might develop a new type of biomaterial for artificial organs and partner with a medical device company to bring it to market. Conclusion Europe's artificial organs and bionics market is a global leader in quality and innovation. With a focus on advanced research, stringent regulations, and collaborative efforts, Europe is well-positioned to develop the next generation of life-saving technologies. As the market embraces digitalization, sustainability practices, and open collaboration, European artificial organs and bionics have the potential to improve the lives of millions of patients worldwide and solidify Europe's position at the forefront of this transformative medical field.

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 19
  • 2.1 Market Size and Forecast 19
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 23
  • 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 25
  • 2.2 Major Growth Drivers 29
  • 2.3 Market Restraints and Challenges 33
  • 2.4 Emerging Opportunities and Market Trends 36
  • 2.5 Porter’s Fiver Forces Analysis 40
  • 3 Segmentation of Europe Market by Product Type 44
  • 3.1 Market Overview by Product Type 44
  • 3.2 Artificial Organ 46
  • 3.2.1 Kidney 48
  • 3.2.2 Heart 49
  • 3.2.3 Liver 50
  • 3.2.4 Lungs 51
  • 3.2.5 Pancreas 52
  • 3.2.6 Other Organs 53
  • 3.3 Artificial Bionics 54
  • 3.3.1 Ear Bionics 56
  • 3.3.2 Exoskeleton 57
  • 3.3.3 Bionic Limbs 58
  • 3.3.4 Vision Bionics 59
  • 3.3.5 Brain Bionics 60
  • 3.3.6 Cardiac Bionics 61
  • 3.3.7 Other Bionics 62
  • 4 Segmentation of Europe Market by Material 63
  • 4.1 Market Overview by Material 63
  • 4.2 Metals 65
  • 4.3 Polymers 66
  • 4.4 Ceramics 67
  • 4.5 Other Materials 68
  • 5 Segmentation of Europe Market by Technology 69
  • 5.1 Market Overview by Technology 69
  • 5.2 Mechanical 71
  • 5.3 Electronic 72
  • 6 Segmentation of Europe Market by Fixation Type 73
  • 6.1 Market Overview by Fixation Type 73
  • 6.2 Implantable 75
  • 6.3 Wearable 76
  • 7 Segmentation of Europe Market by Age Group 77
  • 7.1 Market Overview by Age Group 77
  • 7.2 17 Years Old and Under 79
  • 7.3 18-34 Years Old 80
  • 7.4 35-49 Years Old 81
  • 7.5 50-64 Years Old 82
  • 7.6 65 Years Old and Above 83
  • 8 Segmentation of Europe Market by End User 84
  • 8.1 Market Overview by End User 84
  • 8.2 Hospitals 86
  • 8.3 Ambulatory Surgical Centers (ASCs) 87
  • 8.4 Other End Users 88
  • 9 European Market 2022-2032 by Country 89
  • 9.1 Overview of European Market 89
  • 9.2 Germany 92
  • 9.3 U.K. 94
  • 9.4 France 96
  • 9.5 Spain 98
  • 9.6 Italy 100
  • 9.7 Netherlands 102
  • 9.8 Rest of European Market 104
  • 10 Competitive Landscape 106
  • 10.1 Overview of Key Vendors 106
  • 10.2 New Product Launch, Partnership, Investment, and M&A 109
  • 10.3 Company Profiles 110
  • Abbott Laboratories Inc. 110
  • Abiomed, Inc. 112
  • Berlin Heart GmbH 113
  • Biomet Inc. 114
  • Boston Scientific Corporation 115
  • Cochlear Ltd. 116
  • Edward Lifesciences Corporation 117
  • Ekso Bionics Holdings, Inc. 118
  • Iwalk Inc. 119
  • Jarvik Heart, Inc. 120
  • Medtronic Plc 121
  • Össur hf. 122
  • ReWalk Robotics Ltd. 123
  • SynCardia Systems LLC 124
  • Zimmer Biomet Holdings Inc. 125
  • RELATED REPORTS 126



Table 1. Snapshot of Europe Artificial Organ and Bionics Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. Scenarios for Economic Impact of Ukraine Crisis 26
Table 5. Main Product Trends and Market Opportunities in Europe Artificial Organ and Bionics Market 36
Table 6. Europe Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 44
Table 7. Europe Artificial Organ and Bionics Market: Artificial Organ by Type, 2022-2032, $ mn 47
Table 8. Europe Artificial Organ and Bionics Market: Artificial Bionics by Type, 2022-2032, $ mn 55
Table 9. Europe Artificial Organ and Bionics Market by Material, 2022-2032, $ mn 63
Table 10. Europe Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 69
Table 11. Europe Artificial Organ and Bionics Market by Fixation Type, 2022-2032, $ mn 73
Table 12. Europe Artificial Organ and Bionics Market by Age Group, 2022-2032, $ mn 77
Table 13. Europe Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 84
Table 14. Europe Artificial Organ and Bionics Market by Country, 2022-2032, $ mn 91
Table 15. Germany Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 93
Table 16. Germany Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 93
Table 17. Germany Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 93
Table 18. U.K. Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 95
Table 19. U.K. Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 95
Table 20. U.K. Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 95
Table 21. France Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 97
Table 22. France Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 97
Table 23. France Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 97
Table 24. Spain Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 99
Table 25. Spain Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 99
Table 26. Spain Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 99
Table 27. Italy Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 101
Table 28. Italy Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 101
Table 29. Italy Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 101
Table 30. Netherlands Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 103
Table 31. Netherlands Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 103
Table 32. Netherlands Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 103
Table 33. Artificial Organ and Bionics Market in Rest of Europe by Country, 2022-2032, $ mn 105
Table 34. Abbott Laboratories Inc.: Company Snapshot 110
Table 35. Abbott Laboratories Inc.: Business Segmentation 111
Table 36. Abbott Laboratories Inc.: Product Portfolio 111



Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 16
Figure 4. Europe Artificial Organ and Bionics Market, 2022-2032, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Artificial Organ and Bionics Market 29
Figure 7. Overview of Worldwide Organ Donation and Transplant, 2021 32
Figure 8. Estimated Number of Worldwide Organ Transplants by Organ Type in 2021 32
Figure 9. Primary Restraints and Impact Factors of Europe Artificial Organ and Bionics Market 33
Figure 10. Investment Opportunity Analysis 37
Figure 11. Porter’s Fiver Forces Analysis of Europe Artificial Organ and Bionics Market 40
Figure 12. Breakdown of Europe Artificial Organ and Bionics Market by Product Type, 2022-2032, % of Revenue 45
Figure 13. Europe Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 45
Figure 14. Europe Artificial Organ and Bionics Market by Product Type: Artificial Organ, 2022-2032, $ mn 46
Figure 15. Europe Artificial Organ and Bionics Market by Artificial Organ: Kidney, 2022-2032, $ mn 48
Figure 16. Europe Artificial Organ and Bionics Market by Artificial Organ: Heart, 2022-2032, $ mn 49
Figure 17. Europe Artificial Organ and Bionics Market by Artificial Organ: Liver, 2022-2032, $ mn 50
Figure 18. Europe Artificial Organ and Bionics Market by Artificial Organ: Lungs, 2022-2032, $ mn 51
Figure 19. Europe Artificial Organ and Bionics Market by Artificial Organ: Pancreas, 2022-2032, $ mn 52
Figure 20. Europe Artificial Organ and Bionics Market by Artificial Organ: Other Organs, 2022-2032, $ mn 53
Figure 21. Europe Artificial Organ and Bionics Market by Product Type: Artificial Bionics, 2022-2032, $ mn 54
Figure 22. Europe Artificial Organ and Bionics Market by Artificial Bionics: Ear Bionics, 2022-2032, $ mn 56
Figure 23. Europe Artificial Organ and Bionics Market by Artificial Bionics: Exoskeleton, 2022-2032, $ mn 57
Figure 24. Europe Artificial Organ and Bionics Market by Artificial Bionics: Bionic Limbs, 2022-2032, $ mn 58
Figure 25. Europe Artificial Organ and Bionics Market by Artificial Bionics: Vision Bionics, 2022-2032, $ mn 59
Figure 26. Europe Artificial Organ and Bionics Market by Artificial Bionics: Brain Bionics, 2022-2032, $ mn 60
Figure 27. Europe Artificial Organ and Bionics Market by Artificial Bionics: Cardiac Bionics, 2022-2032, $ mn 61
Figure 28. Europe Artificial Organ and Bionics Market by Artificial Bionics: Other Bionics, 2022-2032, $ mn 62
Figure 29. Breakdown of Europe Artificial Organ and Bionics Market by Material, 2022-2032, % of Sales Revenue 64
Figure 30. Europe Addressable Market Cap in 2023-2032 by Material, Value ($ mn) and Share (%) 64
Figure 31. Europe Artificial Organ and Bionics Market by Material: Metals, 2022-2032, $ mn 65
Figure 32. Europe Artificial Organ and Bionics Market by Material: Polymers, 2022-2032, $ mn 66
Figure 33. Europe Artificial Organ and Bionics Market by Material: Ceramics, 2022-2032, $ mn 67
Figure 34. Europe Artificial Organ and Bionics Market by Material: Other Materials, 2022-2032, $ mn 68
Figure 35. Breakdown of Europe Artificial Organ and Bionics Market by Technology, 2022-2032, % of Sales Revenue 70
Figure 36. Europe Addressable Market Cap in 2023-2032 by Technology, Value ($ mn) and Share (%) 70
Figure 37. Europe Artificial Organ and Bionics Market by Technology: Mechanical, 2022-2032, $ mn 71
Figure 38. Europe Artificial Organ and Bionics Market by Technology: Electronic, 2022-2032, $ mn 72
Figure 39. Breakdown of Europe Artificial Organ and Bionics Market by Fixation Type, 2022-2032, % of Revenue 74
Figure 40. Europe Addressable Market Cap in 2023-2032 by Fixation Type, Value ($ mn) and Share (%) 74
Figure 41. Europe Artificial Organ and Bionics Market by Fixation Type: Implantable, 2022-2032, $ mn 75
Figure 42. Europe Artificial Organ and Bionics Market by Fixation Type: Wearable, 2022-2032, $ mn 76
Figure 43. Breakdown of Europe Artificial Organ and Bionics Market by Age Group, 2022-2032, % of Revenue 78
Figure 44. Europe Addressable Market Cap in 2023-2032 by Age Group, Value ($ mn) and Share (%) 78
Figure 45. Europe Artificial Organ and Bionics Market by Age Group: 17 Years Old and Under, 2022-2032, $ mn 79
Figure 46. Europe Artificial Organ and Bionics Market by Age Group: 18-34 Years Old, 2022-2032, $ mn 80
Figure 47. Europe Artificial Organ and Bionics Market by Age Group: 35-49 Years Old, 2022-2032, $ mn 81
Figure 48. Europe Artificial Organ and Bionics Market by Age Group: 50-64 Years Old, 2022-2032, $ mn 82
Figure 49. Europe Artificial Organ and Bionics Market by Age Group: 65 Years Old and Above, 2022-2032, $ mn 83
Figure 50. Breakdown of Europe Artificial Organ and Bionics Market by End User, 2022-2032, % of Revenue 84
Figure 51. Europe Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 85
Figure 52. Europe Artificial Organ and Bionics Market by End User: Hospitals, 2022-2032, $ mn 86
Figure 53. Europe Artificial Organ and Bionics Market by End User: Ambulatory Surgical Centers (ASCs), 2022-2032, $ mn 87
Figure 54. Europe Artificial Organ and Bionics Market by End User: Other End Users, 2022-2032, $ mn 88
Figure 55. Breakdown of European Artificial Organ and Bionics Market by Country, 2022 and 2032, % of Revenue 90
Figure 56. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 91
Figure 57. Artificial Organ and Bionics Market in Germany, 2022-2032, $ mn 92
Figure 58. Artificial Organ and Bionics Market in U.K., 2022-2032, $ mn 94
Figure 59. Artificial Organ and Bionics Market in France, 2022-2032, $ mn 96
Figure 60. Artificial Organ and Bionics Market in Spain, 2022-2032, $ mn 98
Figure 61. Artificial Organ and Bionics Market in Italy, 2022-2032, $ mn 100
Figure 62. Artificial Organ and Bionics Market in Netherlands, 2022-2032, $ mn 102
Figure 63. Artificial Organ and Bionics Market in Rest of Europe, 2022-2032, $ mn 104
Figure 64. Growth Stage of Europe Artificial Organ and Bionics Industry over the Forecast Period 106
Logo

Europe Artificial Organ and Bionics Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.